Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ouro Fino Saude Animal Participacoes SA
Total Equity
Ouro Fino Saude Animal Participacoes SA
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
|
Total Equity
R$657.6m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
|
Hypera SA
BOVESPA:HYPE3
|
Total Equity
R$12.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
Ouro Fino Saude Animal Participacoes SA
Glance View
Ouro Fino Saúde Animal Participações SA engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals. The firm manufactures veterinary products using scientific technology in the Company's laboratories. The firm's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.
See Also
What is Ouro Fino Saude Animal Participacoes SA's Total Equity?
Total Equity
657.6m
BRL
Based on the financial report for Dec 31, 2025, Ouro Fino Saude Animal Participacoes SA's Total Equity amounts to 657.6m BRL.
What is Ouro Fino Saude Animal Participacoes SA's Total Equity growth rate?
Total Equity CAGR 10Y
6%
Over the last year, the Total Equity growth was -13%. The average annual Total Equity growth rates for Ouro Fino Saude Animal Participacoes SA have been -4% over the past three years , 3% over the past five years , and 6% over the past ten years .
